PharmedOut Publications

PharmedOut Publications and Other Materials

Journal Articles (jump to Consumer Publications)

Pharmacist-industry relatinships
IJPP
Documenting the diverse interactions between pharmacists and the pharmaceutical industry

Direct-to-consumer Marketing to People with Hemophilia
PLOS Medicine
Exposing the relationships that drug manufactureres have with hemophiliac patients and their families.

Salespeople in the Surgical Suite: Relationships between Surgeons and Medical Device Representatives
PLOS One
Why is a device rep in the OR and what does it mean for patient care?

Treatment of Men for 'Low Testosterone': A Systematic Review
PLOS One
A comprehensive review that exposes Testosterone's questionable therapeutic benefits.

Taking Sides: Should Ob/Gyns Prescribe Flibanserin for their Patients?
Contemporary Ob/Gyn
Saying no to this dangerous drug.

CME Stands for Commercial Medical Education: and ACCME Still Won’t Address the Issue
Journal of Medical Ethics
Challenging the ACCME to face the relationship between industry and education.

Hypoactive Sexual Desire Disorder: Inventing a Disease to Sell Low Libido
Journal of Medical Ethics
Exploring how Big Pharma created HSDD to create a disease.

Should Family Physicians Screen for Testosterone Deficiency in Men?
American Family Physician
Dr. Fugh-Berman says No: Screening may be harmful, and benefits are unproven.

Pharmaceutical Industry Interactions in Family Medicine Residencies Decreased Between 2008 and 2013: a CERA Study
Family Medicine
A study that explores pharma influence on family medicine programs.

Physicians under the Influence: Social Psychology and Industry Marketing Strategies
The Journal of Law, Medicine & Ethics
Pharmaceutical and medical device companies apply social psychology to subconsciously influence physicians’ prescribing behavior and decision-making.

How Basic Scientists Help the Pharmaceutical Industry Market Drugs
PLOS Biology
Addresses the presence of pharma influence in biomedical research.

Promoting to Everyone, Focusing on No One: The Illogical Promotion of the Influenza Vaccine
World Medical & Health Policy
The “everyone is at risk” message associated with universal influenza vaccination could undermine effective influenza prevention efforts.

Ethics and Eplerenone
Journal of Medical Ethics
Argues that a placebo-controlled trial is unethical when a comparator that can reasonably be expected to be effective is available

Promotional Tone in Reviews of Menopausal Hormone Therapy After the Women’s Health Initiative: An Analysis of Published Articles
PLoS Medicine

Why Lunch Matters
The Journal of Continuing Education in the Health Professions
Assessing physicians’ perceptions about industry relationships

Do New Drugs Increase Life Expectancy?
Journal of General Internal Medicine
A critique of a Manhattan Institute paper

The Haunting of Medical Journals
PLoS Medicine
How Ghostwriting Sold “HRT”

Ethical Considerations of Publication Planning in the Pharmaceutical Industry
Open Medicine
How industry uses medical writers to manipulate the medical literature

Off-Label Promotion, On-Target Sales
Public Library of Science
The covert promotion of drugs for unapproved uses

Thus Are Our Medical Meetings Managed (also read letter here)
British Medical Journal
Key opinion leaders may be unaware of pharma influence

Prescription Tracking and Public Health
Journal of General Internal Medicine
Why the AMA’s opt-out plan does not protect prescribing privacy

Following the Script: How Drug Reps Make Friends and Influence Doctors
Public Library of Science
Psychological techniques reps use to sell drugs

Doctors Must Not be Lapdogs to Drug Firms
British Medical Journal
Drug reps stomp out of a talk about industry influence

“This May Sting a Bit”: Cutting CME’s Ties to Pharma
Virtual Mentor
CME should go pharma-free

Advertising in Medical Journals: Should Current Practices Change?
PLoS Medicine
Taking ads for luxury goods would be less compromising to medical journals than accepting only drug ads

Gynecologists and Estrogen: An Affair of the Heart
Perspectives in Biology and Medicine
Ob-gyns believe in HT despite evidence

Consumer Publications (back to Journal Articles)

The Score Is Even
Bioethics Forum

EpiPens and the Sale of Fear
Bioethics Forum
How and why drug companies oversell the importance of EpiPens.

EpiPen Furor: Patient Groups Take Money, Stay Mum
Bioethics Forum

The Drug That Cried Feminism
Bioethics Forum

Flibanserin and Regulatory Failure
Journal of Medical Ethics blog

Flibanserin and Feminism
Impact Ethics

Making an Example of Martin Shkreli
Bioethics Forum

LEGGO the Logo? Why Pharma Logos Belong on CME
Bioethics Forum

Outside Opinion: Testosterone treatments are dangerous for men
Chicago Tribune

Device Marketing To Doctors, In and Out of the OR
Women’s Health Activist

Low T, High Profit?
Bioethics Forum

How to Hold Pharma-free Meetings (pdf)

Mammography and the Corporate Breast
Bioethics Forum

Ghostwritten Articles Helped Sell Hormones
Women’s Health Activist

Bone-Breaking Drugs?
Women’s Health Activist

Deceptive Market Practices in the Marketplace of Ideas
Bioethics Forum

Help Your Doctor Break the Sample Habit
Women’s Health Activist

Smoke and Mirrors
Bioethics Forum

Hormones for Hot Flashes – Is “Natural” Better?
Women’s Health Activist

Meds in Kids
Women’s Health Activist

Migraines, Menopause, and Marketing
Women’s Health Activist

Classic Drugs Under Attack
Bioethics Forum

Unsafe IBS Drugs Back on the Market
Women’s Health Activist

Cervical Cancer Vaccines and Industry Influence
Bioethics Forum

The Waiting Room: Pharma’s Latest Lair
Bioethics Forum

The Dog Ate My Disclosure
Bioethics Forum

Hold the Hype on HPV
Women’s Health Activist

Over-the-Counter Sales of Medical Records
Women’s Health Activist

Cervical Cancer Vaccines in Context
Women’s Health Activist

Less Hormone Therapy, Less Breast Cancer
Women’s Health Activist

Big Pharma Wants to Know All About You
Women’s Health Activist

A Bone to Pick with Bone Drugs
Women’s Health Activist

Waiting Room Activism
Women’s Health Activist

Why Race-Based Medicine is a Bad Idea
Women’s Health Activist